19 "COVID-19" clinical trials found.
-
Type I Interferon in COVID-19
The purpose of this research study is to look at the genes (DNA) and biomarkers in the blood of patients that test COVID-positive or are ...Phase N/A
Observational
Accepts Healthy Volunteer
-
Convalescent Plasma To Limit Coronavirus Associated Complications: A Randomized Blinded Phase 2 Study Comparing The Efficacy And Safety Of Anti-Sars-Cov-2 Plasma To Placebo In Covid-19 Hospitalized Patients
The purpose of the study is to find out if convalescent plasma (the liquid portion of blood of patients who recover from COVID-19) can prevent ...Phase
Interventional
-
COVID-19 - Emergency IND
This is a prospective multicenter registry with an embedded open-label randomized clinical trial to determine the effects of standard of care treatment vs. standard of ...Phase
Interventional
-
COVID 19 Intervention: Influence of ECMO on Cytokine Storm with/without Cytokine Filtration
Approximately 8-10% of ventilator dependent patients are being placed on ECMO (extracorporeal membrane oxygenation) for adult respiratory distress syndrome during the COVID 19 pandemic. The ... -
COVID-19 AND LACTATING MOTHERS (CALM): AN OBSERVATIONAL STUDY OF COVID-19 TRANSMISSION RISKS BETWEEN PARENT AND CHILD THROUGH HUMAN LACTATION
The purpose of this study is to determine if there may be virus causing COVID-19 in breast milk, skin swabs and blood samples we collect ...Phase N/A Accepts Healthy Volunteer
-
A Phase 1/2 Placebo-Controlled Randomized Observer-Blind Dose-Finding Study to Describe the Safety Tolerability Immunogenicity and Potential Efficacy of SARS CoV 2 RNA Vaccine Candidates Against COVID 19 in Healthy Adults
The World Health Organization (WHO) has declared COVID-19 to be a pandemic; finding a vaccine to prevent COVID-19 is an urgent need. The study will ...Phase
Accepts Healthy Volunteer
-
A Multicenter Adaptive Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults
COVID-19 is a respiratory disease caused by a novel coronavirus (SARS-CoV-2) and causes substantial morbidity and mortality. There are no approved medicines to treat COVID-19 ...Phase
Interventional
-
Efficacy of Hydroxychloroquine for Post-exposure Prophylaxis (PEP) to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Adults Exposed to Coronavirus Disease (COVID-19): a Blinded Randomized Study
The purpose of this study is to understand if taking a malaria, autoimmunity, and arthritis medication called hydroxychloroquine can reduce the risk of becoming infected ...Phase
-
A Phase 2 Study of BIO 300 in Patients with COVID-19
COVID-19 is caused by a virus that triggers inflammation of the lungs. This inflammation may damage the lungs and lead to scarring. This scarring causes ...Phase
Interventional
-
A Multicenter Adaptive Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitalized Adults with COVID-19
Patients with COVID-19 disease are at risk of blood clots, which may affect many parts of the body. The purpose of this study is to ...Phase
Interventional
